13D/13G Filings - Dianthus Therapeutics Inc. (DNTH)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
4:58 pm
Purchase
2023-12-3113GDianthus Therapeutics, Inc.
DNTH
Citadel Advisors LLC2,880
0.000%
2,880increase
(New Position)
Filing
History
2024-02-14
4:16 pm
Purchase
2023-12-3113GDianthus Therapeutics, Inc.
DNTH
5AM Partners VII, LLC 1,682,584
5.700%
200,264increase
(+13.51%)
Filing
History
2024-02-14
4:15 pm
Unchanged
2023-12-3113GDianthus Therapeutics, Inc.
DNTH
Third Rock Ventures IV, L.P.0
0.000%
0
(Unchanged)
Filing
History
2024-02-09
4:10 pm
Purchase
2023-12-3113GDianthus Therapeutics, Inc.
DNTH
GV 2016, L.P. 208,697
1.400%
208,697increase
(New Position)
Filing
History
2024-02-02
4:32 pm
Purchase
2024-01-2413GDianthus Therapeutics, Inc.
DNTH
BCLS Fund III Investments, LP2,992,028
9.990%
2,992,028increase
(New Position)
Filing
History
2024-02-01
6:22 pm
Purchase
2024-01-2213GDianthus Therapeutics, Inc.
DNTH
RA CAPITAL MANAGEMENT L.P.2,995,023
9.990%
2,995,023increase
(New Position)
Filing
History
2024-01-31
12:11 pm
Purchase
2024-01-2213DDianthus Therapeutics, Inc.
DNTH
Avidity Partners Management LP2,922,823
9.900%
2,922,823increase
(New Position)
Filing
History
2024-01-24
5:26 pm
Purchase
2024-01-2213DDianthus Therapeutics, Inc.
DNTH
Fairmount Funds Management LLC2,960,747
9.900%
1,086,914increase
(+58.00%)
Filing
History
2023-11-13
09:02 am
Purchase
2023-11-1013GDianthus Therapeutics, Inc.
DNTH
FMR LLC2,218,212
14.970%
2,218,212increase
(New Position)
Filing
History
2023-09-21
4:34 pm
Purchase
2023-09-1113DDianthus Therapeutics, Inc.
DNTH
Viridian LLC1,090,283
7.400%
1,090,283increase
(New Position)
Filing
History
2023-09-21
4:32 pm
Purchase
2023-09-1113DDianthus Therapeutics, Inc.
DNTH
Fairmount Funds Management LLC1,873,833
12.700%
1,873,833increase
(New Position)
Filing
History
2023-09-21
4:15 pm
Purchase
2023-09-1113GDianthus Therapeutics, Inc.
DNTH
5AM Partners VII, LLC 1,482,320
10.000%
1,482,320increase
(New Position)
Filing
History
2023-09-21
4:15 pm
Purchase
2023-09-1113GDianthus Therapeutics, Inc.
DNTH
Venrock Healthcare Capital Partners III, L.P.927,706
6.300%
927,706increase
(New Position)
Filing
History
2023-09-15
4:56 pm
Purchase
2023-09-1113DDianthus Therapeutics, Inc.
DNTH
Atlas Venture Fund X L.P.186,089
1.300%
186,089increase
(New Position)
Filing
History
2023-05-15
4:47 pm
Purchase
2023-05-0313GMagenta Therapeutics, Inc.
MGTA
Citadel Advisors LLC4,087,110
6.700%
4,087,110increase
(New Position)
Filing
History
2023-02-14
4:45 pm
Sale
2022-12-3113GMagenta Therapeutics, Inc.
MGTA
RA CAPITAL MANAGEMENT L.P.0
0.000%
-3,588,081decrease
(Position Closed)
Filing
History
2023-02-14
11:12 am
Sale
2022-12-3113GMagenta Therapeutics, Inc.
MGTA
Aquilo Capital Management LLC0
0.000%
-3,155,082decrease
(Position Closed)
Filing
History
2023-02-14
08:47 am
Sale
2022-12-3113GMagenta Therapeutics, Inc.
MGTA
Deep Track Capital, LP3,000,000
4.950%
-1,870,000decrease
(-38.40%)
Filing
History
2023-02-14
06:09 am
Sale
2022-12-3113GMagenta Therapeutics, Inc.
MGTA
GILDER GAGNON HOWE & CO LLC425,858
0.700%
-3,249,750decrease
(-88.41%)
Filing
History
2023-02-13
9:31 pm
Sale
2022-12-3113GMagenta Therapeutics, Inc.
MGTA
Casdin Capital LLC0
0.000%
-3,901,589decrease
(Position Closed)
Filing
History
Goto Prev, 0, 1, 2, Next